Table 3.
Unadjusted Rates of Impaired Cognitive Performance on Each Test at 12 Months
| Cognitive Test | Percentage With Impaired Performance* |
P† | |
|---|---|---|---|
| ADT+ | Controls | ||
| Verbal memory | |||
| HVLT-R Total Recall | 14 | 5 | .33 |
| HVLT-R Delayed Recall | 26 | 11 | .10 |
| WMS-III Logical Memory II | 4 | 6 | .27 |
| Visual memory | |||
| BVMT-R Total Recall | 14 | 5 | .25 |
| BVMT-R Delayed Recall | 10 | 6 | .92 |
| Attention | |||
| Color Trails 1 | 16 | 5 | .08 |
| WMS-III Digit Span | 2 | 1 | .85 |
| WMS-III Spatial Span | 2 | 1 | .93 |
| SDMT | 0 | 0 | — |
| Executive function | |||
| Color Trails 2 | 16 | 4 | .05 |
| COWA | 14 | 5 | .17 |
| TIADL | 2 | 1 | .83 |
Abbreviations: ADT+, patients with prostate cancer receiving androgen-deprivation therapy; BVMT-R, Brief Visuospatial Memory Test–Revised; COWA, Controlled Oral Word Association Test; HVLT-R, Hopkins Verbal Learning Test–Revised; SDMT, Symbol Digit Modalities Test; TIADL, Timed Instrumental Activities of Daily Living Test; WMS-III, Wechsler Memory Scale–III.
*
≥ 2.0 standard deivations below norms on ≥ one test.
†
P values calculated using logistic regression analyses controlling for medical comorbidities, race, and years of education.